Brief: Caplin Point Laboratories Says Caplin Steriles Gets USFDA Approval For Difluprednate Ophthalmic Emulsion
16/12/2024 08:40
Dec 16 (Reuters) - Caplin Point Laboratories Ltd
CAPL.NS :
* CAPLIN STERILES GETS USFDA APPROVAL FOR DIFLUPREDNATE
OPHTHALMIC
EMULSION
Source text: ID:nBSE45J10K
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees